Alemtuzumab induction in simultaneous pancreas and kidney transplantation-Reference-Cited by-同舟云学术

Alemtuzumab induction in simultaneous pancreas and kidney transplantation

Published:2013-08 Issue: Volume: Page:n/a-n/a
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Zachariah Mareena¹,Gregg Austin²,Schold Jesse³,Magliocca Joseph⁴,Kayler Liise K.⁵

Affiliation:

1. Department of Medicine; State University New York at Buffalo; Buffalo; NY; USA

2. Department of Medicine; University of Florida; Gainesville; FL; USA

3. Department of Quantitative Health Sciences; Cleveland Clinic; Cleveland; OH; USA

4. Department of Surgery; Emory; Atlanta; GA; USA

5. Department of Surgery; Montefiore Medical Center; Bronx; NY; USA

Publisher

Wiley

Subject

Transplantation

Reference37 articles.

1. Pancreas transplant outcomes for United States (US) cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR) as of October, 2000;Gruessner;Clin Transpl,2000

2. Chronic rejection: the next major challenge for pancreas transplant recipients;Humar;Transplantation,2003

3. Simultaneous kidney-pancreas transplantation without antilymphocyte induction;Reddy;Transplantation,2000

4. Analyses of pancreas transplant outcomes for United States cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR);Gruessner;Clin Transpl,1999

5. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis;Stratta;Clin Transplant,2002

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive update of the metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation;Expert Opinion on Drug Metabolism & Toxicology;2023-07-03

2. Outcomes of Primary Simultaneous Pancreas-kidney Transplants by Induction Agent in the United States;Transplantation Direct;2022-11-17

3. Working towards an ERAS Protocol for Pancreatic Transplantation: A Narrative Review;Journal of Clinical Medicine;2021-04-01

4. Immunosuppression considerations in simultaneous organ transplant;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-01

5. Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor- and Steroid-Free Regimen for Pancreas Transplant Recipients;Canadian Journal of Infectious Diseases and Medical Microbiology;2020-10-10